JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HENDLEY, E. D.
Right arrow Articles by LaPIDUS, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HENDLEY, E. D.
Right arrow Articles by LaPIDUS, J. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 183, Issue 1, 103-116, 1972
Copyright © 1972 by American Society for Pharmacology and Experimental Therapeutics


STEREOSELECTIVITY OF CATECHOLAMINE UPTAKE BY BRAIN SYNAPTOSOMES: STUDIES WITH EPHEDRINE, METHYLPHENIDATE AND PHENYL-2-PIPERIDYL CARBINOL

EDITH D. HENDLEY 1, SOLOMON H. SNYDER 1, JON J. FAULEY 1, and JULES B. LaPIDUS 1

1 Departments of Pharmacology and Experimental Therapeutics and Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Medicinal Chemistry, The Ohio state University, College of Pharmacy, Columbus, Ohio

In this study we examined the stereoselectivity of catecholamine uptake into synaptosomes prepared from rat cerebral cortex or corpus striatum with isomers of ephedrine, methylphenidate and phenyl-2-piperidyl carbinol, compounds possessing two asymmetric carbons, hence, four possible stereoisomers. The four ephedrine isomers were more potent inhibitors of catecholamine uptake in the cerebral cortex than in the corpus striatum. There was a 100-fold variation in potency among the ephedrine isomers in the cerebral cortex but only a 7-fold variation in the corpus striatum. The optimal configuration at the agr (S) and beta(R) carbons (erythro configuration) for activity of the ephedrines in both brain regions corresponds to the configurations of (+)-amphetamine and (-)-norepinephrine, respectively. In contrast, the four phenyl-2-piperidyl carbinol isomers were more potent in the corpus striatum than in the cerebral cortex, and the configuration of the most potent isomer was R at both agr and beta carbons, i.e., threo. Also unlike the ephedrines, there was a greater variation in potency among the various phenyl-2-piperidyl carbinol isomers in the striatum than in the cerebral cortex. The methylphenidates, like phenyl-2-piperidyl carbinol, were more potent inhibitors of catecholamine uptake in the corpus striatum than in the cerebral cortex, and the threo racemate of methylphenidate was about 100 times more active than the erythro racemate in both areas. Although ephedrine, amphetamine and norepinephrine isomers show much less stereoselectivity in the corpus striatum than in the cerebral cortex, phenyl-2-piperidyl carbinol and methylphenidate isomers display more stereoselectivity in the corpus striatum than in the cerebral cortex. The relative activity among phenyl-2-piperidyl carbinol and methylphenidate isomers in inhibiting catecholamine uptake is opposite to that of ephedrine isomers.

Submitted on April 29, 1971
Accepted on May 23, 1972




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
M. Ishimatsu, Y. Kidani, A. Tsuda, and T. Akasu
Effects of Methylphenidate on the Membrane Potential and Current in Neurons of the Rat Locus Coeruleus
J Neurophysiol, March 1, 2002; 87(3): 1206 - 1212.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. H. Snyder, S. P. Banerjee, H. I. Yamamura, and D. Greenberg
Drugs, Neurotransmitters, and Schizophrenia
Science, June 21, 1974; 184(4143): 1243 - 1253.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics.